UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other juris ...

Aspen Aerogels, Inc. (NYSE:ASPN) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Neal Baranosky - Senior Director of Corporate of Strategy & Finance Donald Young - President & Chief Executive Officer Ricardo Rodriguez - Chief Financial Officer Conference Call Participants Eric Stine - Craig-Hallum Alex Potter - Piper Sandler Jeffrey Osborne - TD Cowen George Gianarikas - Canaccord Genuity Christopher Souther - B. Riley Thomas Curran - Seaport Amit Dayal - H.C. Wainwright Coli ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other jurisdicti ...

Financial Data and Key Metrics Changes - The company reported Q1 2023 revenues of $45.6 million, representing a 19% year-over-year growth [28] - Adjusted EBITDA was negative $13.9 million, an improvement from negative $14.6 million in Q1 2022, indicating a 5% reduction in EBITDA loss year-over-year [33] - The net loss for Q1 2023 decreased to $16.8 million or $0.24 per share, compared to a net loss of $19.5 million or $0.59 per share in the same quarter of 2022 [34] Business Line Data and Key Metrics Changes - Energy industrial revenues for Q1 were $33.9 million, which is 2% lower than the previous quarter but 10% higher year-over-year [28] - EV thermal barrier revenues were $11.7 million, reflecting a 53% year-over-year increase but a 54% decrease quarter-over-quarter due to a prior supplemental order from General Motors [29] Market Data and Key Metrics Changes - The company anticipates a strong energy industrial backlog with purchase orders for 2023 amounting to approximately $180 million [11] - The expected thermal barrier revenue for 2023 is projected to be between $70 million and $100 million, with a significant ramp-up expected in 2024 [13] Company Strategy and Development Direction - The company aims to balance demand, supply, and financing while focusing on profitability and capital preservation during potential economic uncertainty [12] - A manufacturing agreement with a Chinese aerogel manufacturer is expected to support the energy industrial business starting January 2024, allowing the company to dedicate its existing manufacturing capacity to EV thermal barriers [14] - The strategy includes right-timing the construction of Plant 2 to align with the revenue ramp of EV OEMs, with an estimated revenue capacity of $500 million to $600 million [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a revenue outlook of $200 million to $250 million for 2023, driven by a strong backlog and expected growth from EV customers [8] - The company is taking a conservative approach to capital expenditures, reducing them to less than $150 million for 2023 while focusing on generating positive cash flow [22] - Management highlighted ongoing discussions with lawmakers regarding safety regulations for battery electric vehicles, indicating a proactive approach to regulatory changes [18] Other Important Information - The company has a cash balance of $207.5 million at the end of Q1 2023, which, combined with a $100 million loan commitment from General Motors, provides significant liquidity [25] - The company has refrained from selling equity below the share price of its most recent offering, indicating a focus on minimizing dilution [27] Q&A Session Summary Question: Breakdown of the $3 billion target for awards - Management indicated that the $3 billion figure represents a handful of opportunities, with potential for larger future awards as OEM vehicle rollout plans become clearer [54][55] Question: Considerations for contract manufacturing and IP protection - Management confirmed that the contract manufacturing agreement will meet their specifications and quality standards, with a strong focus on protecting intellectual property [56][57] Question: Competitive landscape for thermal management solutions - Management noted that while there are multiple entrants in the market, the technical dialogue required for awards is complex, and the company feels well-positioned against competitors [66][68] Question: Financing options and market dynamics - Management emphasized a focus on financing options that minimize dilution, with a clear line of sight to existing financing opportunities [70]

May 4, 2023 ASPEN AEROGELS Q1 2023 FINANCIAL RESULTS CALL Disclaimer on Forward Looking Statements This presentation and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's 2023 finan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other jurisdict ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36481 ASPEN AEROGELS, INC. (Exact name of registrant as specified in its charter) Delaware 04-3559972 (State or other jurisdiction o ...

Aspen Aerogels, Inc. (NYSE:ASPN) Q4 2022 Earnings Conference Call February 16, 2023 8:30 AM ET Company Participants Laura Guerrant - VP, IR and Corporate Communications Don Young - President and CEO Ricardo Rodriguez - CFO Conference Call Participants Eric Stine - Craig-Hallum Colin Rusch - Oppenheimer Chris Souther - B. Riley Alex Potter - Piper Sandler George Gianarikas - Canaccord Genuity Jeff Osborne - Cowen Amit Dayal - H.C. Wainwright Operator Good morning. Thank you for attending Aspen Aerogels, Inc. ...